Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 70 of 70 entries
View as:

Functional Evaluation After Breast Reconstruction With a Minimally Invasive Latissimus Dorsi Flap Following Radical Surgery for Breast Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT05278741 Org: User:
Start: 11/25/22 End: 05/25/26 Due: 05/25/27

Evaluation of the Accuracy of Percutaneous Biopsy by Vacuum-assisted Biopsy (VAB) to Assess Pathological Complete Response in Patients With Clinical and Radiological Complete Response After Neoadjuvant Chemotherapy (NeoVAB)

Phase: N/A Priority: Normal
NCT ID: NCT03876951 Org: User:
Start: 08/30/19 End: 04/08/25 Due: 04/08/26

Evaluation of the Efficacy and the Safety of FOLFIRINOX3 Bevacizumab Treatment in Patients With Colorectal Cancer (FOLFIRINOX 3)

Phase: N/A Priority: Normal
NCT ID: NCT03795311 Org: User:
Start: 11/07/18 End: 07/16/25 Due: 07/16/26

FCH vs FDG PET/CT in Detection of Lesions in Patients With Multiple Myeloma (MIM)

Phase: N/A Priority: Normal
NCT ID: NCT04349358 Org: User:
Start: 12/15/20 End: 12/15/30 Due: 12/15/31

Study Evaluating the Efficacy and the Tolerance of Pelvic-prostatic Hypo-fractionated Radiotherapy Followed by Boost in Patients With Prostate Adenocarcinoma Adverse Intermediate Risk or High Localized Risk

Phase: N/A Priority: Normal
NCT ID: NCT03417336 Org: User:
Start: 01/24/18 End: 04/24/29 Due: 04/24/30

Characteristics of the Intestinal Microbiota in Patients With Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03196609 Org: User:
Start: 02/06/17 End: 07/05/18 Due: 07/05/19

Thyroid Cancer Database

Phase: N/A Priority: Normal
NCT ID: NCT04031638 Org: User:
Start: 01/01/00 End: 01/01/25 Due: 01/01/26

Multimetabolic 18F-Fluorodeoxyglucose (FDG) and 18F-Fluorocholine (FCH) Positron Emission Tomography (PET) as an Early Predictive Factor of Overall Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib

Phase: N/A Priority: Normal
NCT ID: NCT02847468 Org: User:
Start: 03/27/17 End: 12/23/21 Due: 12/23/22

Metastatic Colorectal Cancer Database

Phase: N/A Priority: Normal
NCT ID: NCT04031625 Org: User:
Start: 11/26/12 End: 11/30/22 Due: 11/30/23

Evaluation of the Dose Received by the Prostate With in Vivo Dosimetry in Patients Treated With Daily IGRT Associated With IMRT Using Two Repositioning Techniques for Localized Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02279693 Org: User:
Start: 12/22/14 End: 08/06/19 Due: 08/06/20

Predictive Study of Radiation Induced Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT01504360 Org: User:
Start: 12/31/11 End: 06/30/17 Due: 06/30/18

Optimizing the Management of Patients With Oral Therapy

Phase: N/A Priority: Normal
NCT ID: NCT03623490 Org: User:
Start: 05/22/18 End: 05/11/21 Due: 05/11/22

Study of Cancer Patients' Preferences for Genetic Information Modalities Preceding Theranostic Exome Analysis.

Phase: N/A Priority: Normal
NCT ID: NCT06550687 Org: User:
Start: 09/19/24 End: 11/01/26 Due: 11/01/27

Feasibility of the Research for Mutation of K-ras and EGFR in CTCs From Metastatic Non Small Cells Bronchial Carcinomas

Phase: N/A Priority: Normal
NCT ID: NCT01380795 Org: User:
Start: 03/09/11 End: 06/30/19 Due: 06/30/20

Clinical Trial Evaluating the Safety and Efficacy of Chemoimmunotherapy Plus Short Course of Mek Inhibitor in First Line of Treatment of Metastatic Non Squamous Non Small Cell Lung Adenocarcinoma With PDL1 < 50 %.

Phase: N/A Priority: Normal
NCT ID: NCT05937906 Org: User:
Start: 07/30/24 End: 05/25/28 Due: 05/25/29

Hepatic Arterial Chemotherapy With Raltitrexed and Oxaliplatin Versus Standard Chemotherapy in Unresectable Liver Metastases From Colorectal Cancer After Conventional Chemotherapy Failure

Phase: N/A Priority: Normal
NCT ID: NCT01348412 Org: User:
Start: 12/15/10 End: 04/18/18 Due: 04/18/19

Relevance of T Lymphocytes Tumor Infiltrates CD8 and Foxp3 as Immune Prognostic Biomarker in Breast Cancer Treated by Neo Adjuvant Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01513408 Org: User:
Start: 05/31/12 End: 10/31/25 Due: 10/31/26

Validation of a Genetic Signature to Predict the Development of Sarcomas

Phase: N/A Priority: Normal
NCT ID: NCT03625791 Org: User:
Start: 06/19/18 End: 06/19/22 Due: 06/19/23

Study of the Specific Seroprevalence of SARS-CoV-2 in a Sample of Patients and Salaried Staff From a French Anti-cancer Center at the End of the Containment Period of the SARS-CoV-2 Pandemic

Phase: N/A Priority: Normal
NCT ID: NCT04517097 Org: User:
Start: 05/12/20 End: 06/30/20 Due: 06/30/21

Use of an Ultra-rapid BRCA1/2 Status Screening Test in Diagnostic and Theranostic Indication: Performance and Interest for Patients and Practitioners

Phase: N/A Priority: Normal
NCT ID: NCT06111417 Org: User:
Start: 06/12/24 End: 09/12/26 Due: 09/12/27